Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oxidative Medicine and Cellular Longevity is Scopus-indexed (Q1, CiteScore 20.1). Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1942-0900Verify ISSN ↗1942-0994Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$2,680 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry | 18 / 448 | 96th | Q1 |
| Aging | 3 / 42 | 94th | Q1 |
| Cell Biology | 22 / 289 | 92nd | Q1 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 20.1.
Oxidative Medicine and Cellular Longevity is Q1 in Biochemistry (rank 18 of 448), Q1 in Aging (rank 3 of 42) and Q1 in Cell Biology (rank 22 of 289), by CiteScore 2025.
Oxidative Medicine and Cellular Longevity is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 20.1, quartile Q1, 96th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.643, quartile Q1, with an H-index of 188.
The publisher lists an article processing charge of about US$2,680 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Oxidative Medicine and Cellular Longevity is published by John Wiley and Sons Ltd. Its print ISSN is 1942-0900 and its online ISSN is 1942-0994.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Oxidative Medicine and Cellular Longevity has an h-index of 216 and a 2-year mean of 1.14 citations per paper (OpenAlex). Its Scopus CiteScore is 20.1, quartile Q1. On 2-year citations it ranks #341 of 442 Scopus journals in Biochemistry.
Oxidative Medicine and Cellular Longevity published 67 papers in 2025; its busiest recent year was 2022 with 1,334. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 60 research articles (2024–2026), authors are most often from Iran (21.4%), United States (11.7%) and India (9.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 504 retracted papers are recorded (65.6 per 1,000 papers). The Problematic Paper Screener flags 12 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.